|
LOBBYING REPORT |
Lobbying Disclosure Act of 1995 (Section 5) - All Filers Are Required to Complete This Page
2. Address
| Address1 | 3540 Crain Highway |
Address2 | Ste. 675 |
| City | Bowie |
State | MD |
Zip Code | 20716 |
Country | USA |
3. Principal place of business (if different than line 2)
| City |
|
State |
|
Zip Code |
|
Country |
|
|
5. Senate ID# 13723-12
|
||||||||
|
6. House ID# 333440000
|
||||||||
| TYPE OF REPORT | 8. Year | 2024 |
Q1 (1/1 - 3/31) | Q2 (4/1 - 6/30) | Q3 (7/1 - 9/30) | Q4 (10/1 - 12/31) |
9. Check if this filing amends a previously filed version of this report
| 10. Check if this is a Termination Report | Termination Date |
|
11. No Lobbying Issue Activity |
| INCOME OR EXPENSES - YOU MUST complete either Line 12 or Line 13 | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| 12. Lobbying | 13. Organizations | ||||||||
| INCOME relating to lobbying activities for this reporting period was: | EXPENSE relating to lobbying activities for this reporting period were: | ||||||||
|
|
||||||||
|
|
||||||||
| Provide a good faith estimate, rounded to the nearest $10,000, of all lobbying related income for the client (including all payments to the registrant by any other entity for lobbying activities on behalf of the client). | 14. REPORTING Check box to indicate expense accounting method. See instructions for description of options. | ||||||||
|
Method A.
Reporting amounts using LDA definitions only
Method B. Reporting amounts under section 6033(b)(8) of the Internal Revenue Code Method C. Reporting amounts under section 162(e) of the Internal Revenue Code |
|||||||||
| Signature | Digitally Signed By: Laura Weidner |
Date | 7/12/2024 3:24:11 PM |
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code BUD
16. Specific lobbying issues
-Labor, Health and Human Services, Education and Related Agencies Appropriations Act, 2025, support funding for epilepsy programs and research including $11.581 billion for the CDC including $12.5 million for the CDCs Epilepsy program, $164 million for the Safe Motherhood and Infant Health program, $51.3 billion for the NIH, $740 million for the BRAIN Initiative, $15 million to start considering an epilepsy-related research and clinical consortium at the NIH, $10 million for the National Neurological Conditions Surveillance System and increased funding for the Social Security Administration.
-Military Construction, Veterans Affairs, and Related Agencies Appropriations Act, 2025, support at least $26.8 million for the VA Epilepsy Centers of Excellence.
-Agriculture, Rural Development, Food and Drug Administration and Related Agencies Appropriations Act, 2025, support robust funding for the Food& Drug Administrations BA.
-Defense Appropriations Act, 2025, within the Congressionally Directed Medical Research Programs, support $12 million for the Epilepsy Program,$10 million for the Tuberous Sclerosis Complex program and $175 million for the TBI and Psychological Health Program.
17. House(s) of Congress and Federal agencies Check if None
U.S. SENATE, U.S. HOUSE OF REPRESENTATIVES
18. Name of each individual who acted as a lobbyist in this issue area
| First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Laura |
Weidner |
|
|
|
Tyler |
Beck |
|
|
|
Roxanne |
Yaghoubi |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code HCR
16. Specific lobbying issues
-S. 652/H.R. 2630, Safe Step Act, support passage.
-S. 1375/H.R. 830, HELP Copays Act, support passage.
-S. 1339, PBM Reform Act, support patient-centric reforms including addition of the Safe Step Act and HELP Copays Act.
-H.R. 2880, Protecting Patients Against PBM Abuses Act-Support preservation of Medicare Part Ds Six Protected Classes policy.
-Protection of the Affordable Care Act and Reauthorization of the Advance Premium Tax Credits
-Support patient-centric implementation of Medicare Part D out-of-pocket cap and the Medicare Prescription Payment Plan
-Educate about Medicaid and CHIP unwinding to try and reduce coverage losses.
-Urge the federal government to collect better data on the disability community
-Urge patient priorities like standardized health plans and network adequacy in the 2026 Notice of Benefit and Payment Parameters rule.
-Urge rescission of the 2018 Definition of Employer-Association Health Plans final rule (the 2018 AHP Rule).
-Urge finalization of regulations important to patients and consumers with acute and chronic health conditions including the 504 rule, short-term limited duration rule and the 1557 rule.
-ERISA RFI, comments to help ensure that people with serious acute and chronic health care conditions who are covered by employer-sponsored plans are protected and have coverage that meets their health care needs
-Ensure any regulation of cannabis protects safe and legal access
-Ensure continued access to needed healthcare via telehealth including prescribing of epilepsy medications that are controlled substances
-Requests to join the Congressional Epilepsy Caucus.
-H.R. 824, the Telehealth Benefit Expansion for Workers Act, oppose passage.
-Support the parity of coverage of mental health treatments
-Support legislation and regulations that incentivize the development of orphan drugs
-Support legislation and regulations that help to advance health equity for people with epilepsy
-Provide technical assistance on draft bill that would establish a federal grant and subgrant program to better support students with epilepsy in schools
-Support legislation and regulations that would ban the use of electric shock devices that apply a shock to a persons skin to reduce or cease self-injurious or aggressive behaviors
-Supporting legislation and regulations that protect the current structure of the National Institutes of Health
-Supporting regulations to change the dates for the New Technology Add-On Payment
-Support legislation to keep insurance brokers accountable
-Support H.R. 7573, Stop Medicaid Recovery Act
-Support H.R. 4758/S.2372, Accelerating Kids Access to Care Act
-Support legislation and regulations to streamline prior authorization processes
-Support the creation of an Office of Caregiving at the Department of Health and Human Services
17. House(s) of Congress and Federal agencies Check if None
U.S. SENATE, U.S. HOUSE OF REPRESENTATIVES, Centers For Medicare and Medicaid Services (CMS), Health & Human Services - Dept of (HHS), Labor - Dept of (DOL), Treasury - Dept of
18. Name of each individual who acted as a lobbyist in this issue area
| First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Laura |
Weidner |
|
|
|
Tyler |
Beck |
|
|
|
Roxanne |
Yaghoubi |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code CIV
16. Specific lobbying issues
-Include provisions in FAA reauthorization to make air travel more accessible for passengers with disabilities and to update which medications are part of airplane medical emergency kits
-S. 545/H.R. 1267, Air Carrier Access Amendments Act, support passage.
-Response to DOT RFI on accessibility of transportation facilities
-Response to DOT RFI on Opportunities and Challenges of Artificial Intelligence in Transportation
-H.R. 6551, Heroes Earned Affordable Lifts (HEAL) Act, support passage
17. House(s) of Congress and Federal agencies Check if None
U.S. SENATE, U.S. HOUSE OF REPRESENTATIVES, Transportation - Dept of (DOT), Justice - Dept of (DOJ)
18. Name of each individual who acted as a lobbyist in this issue area
| First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Tyler |
Beck |
|
|
|
Roxanne |
Yaghoubi |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
Information Update Page - Complete ONLY where registration information has changed.
20. Client new address
| Address |
|
||||||
| City |
|
State |
|
Zip Code |
|
Country |
|
21. Client new principal place of business (if different than line 20)
| City |
|
State |
|
Zip Code |
|
Country |
|
22. New General description of client’s business or activities
LOBBYIST UPDATE
23. Name of each previously reported individual who is no longer expected to act as a lobbyist for the client
|
|
||||||||
| 1 |
|
3 |
|
||||||
| 2 |
|
4 |
|
ISSUE UPDATE
24. General lobbying issue that no longer pertains
|
|
|
|
|
|
|
|
|
AFFILIATED ORGANIZATIONS
25. Add the following affiliated organization(s)
Internet Address:
| Name | Address |
Principal Place of Business (city and state or country) |
||||||||||||
| ||||||||||||||
|
||||||||||||||
26. Name of each previously reported organization that is no longer affiliated with the registrant or client
| 1 | 2 | 3 |
FOREIGN ENTITIES
27. Add the following foreign entities:
| Name | Address |
Principal place of business (city and state or country) |
Amount of contribution for lobbying activities | Ownership percentage in client | ||||||||||
| ||||||||||||||
|
% | |||||||||||||
28. Name of each previously reported foreign entity that no longer owns, or controls, or is affiliated with the registrant, client or affiliated organization
| 1 | 3 | 5 |
| 2 | 4 | 6 |
CONVICTIONS DISCLOSURE
29. Have any of the lobbyists listed on this report been convicted in a Federal or State Court of an offense involving bribery,
extortion, embezzlement, an illegal kickback, tax evasion, fraud, a conflict of interest, making a false statement, perjury, or money laundering?
| Lobbyist Name | Description of Offense(s) |